Talkspace, Inc. (TALK)
USD 3.09
(-5.21%)
USD 3.09
(-5.21%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 97.58 Million USD | -28.95% |
| 2022 | 137.36 Million USD | -14.52% |
| 2021 | 160.69 Million USD | 123.75% |
| 2020 | 71.81 Million USD | 44.9% |
| 2019 | 49.56 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 24.43 Million USD | 4.39% |
| 2024 Q1 | 23.41 Million USD | -0.61% |
| 2024 Q3 | 67.54 Million USD | -11.93% |
| 2023 Q2 | 24.22 Million USD | -6.08% |
| 2023 Q1 | 25.78 Million USD | -17.01% |
| 2023 FY | 97.58 Million USD | -28.95% |
| 2023 Q4 | 23.55 Million USD | -1.97% |
| 2023 Q3 | 24.02 Million USD | -0.79% |
| 2022 Q2 | 35.61 Million USD | -1.69% |
| 2022 Q1 | 36.22 Million USD | -18.68% |
| 2022 FY | 137.36 Million USD | -14.52% |
| 2022 Q4 | 31.07 Million USD | -9.8% |
| 2022 Q3 | 34.44 Million USD | -3.28% |
| 2021 Q1 | 29.9 Million USD | 7.79% |
| 2021 FY | 160.69 Million USD | 123.75% |
| 2021 Q4 | 44.54 Million USD | 13.07% |
| 2021 Q3 | 39.39 Million USD | -15.9% |
| 2021 Q2 | 46.84 Million USD | 56.68% |
| 2020 Q3 | 17.49 Million USD | 35.12% |
| 2020 FY | 71.81 Million USD | 44.9% |
| 2020 Q4 | 27.73 Million USD | 58.55% |
| 2020 Q2 | 12.94 Million USD | 1294700.0% |
| 2020 Q1 | 1000.00 USD | 0.0% |
| 2019 FY | 49.56 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 176.01 Million USD | 44.556% |
| Addus HomeCare Corporation | 248.92 Million USD | 60.795% |
| AirSculpt Technologies, Inc. | 118.32 Million USD | 17.523% |
| Amedisys, Inc. | 834.47 Million USD | 88.305% |
| American Oncology Network, Inc. | 83.97 Million USD | -16.212% |
| Astrana Health, Inc. | 112.59 Million USD | 13.329% |
| Aveanna Healthcare Holdings Inc. | 587.36 Million USD | 83.385% |
| IMAC Holdings, Inc. | 5.02 Million USD | -1841.248% |
| biote Corp. | 98.82 Million USD | 1.252% |
| Cryo-Cell International, Inc. | 35.2 Million USD | -177.199% |
| Cross Country Healthcare, Inc. | 337.69 Million USD | 71.102% |
| COMPASS Pathways plc | 136.91 Million USD | 28.725% |
| DocGo Inc. | 180.32 Million USD | 45.882% |
| The Ensign Group, Inc. | 335.39 Million USD | 70.903% |
| Healthcare Services Group, Inc. | 189.09 Million USD | 48.391% |
| InnovAge Holding Corp. | 558.25 Million USD | 82.519% |
| Assure Holdings Corp. | 15.43 Million USD | -532.094% |
| The Joint Corp. | 109.22 Million USD | 10.652% |
| LifeStance Health Group, Inc. | 491.23 Million USD | 80.134% |
| Mobile-health Network Solutions Class A Ordinary Shares | 18.24 Million USD | -434.965% |
| ModivCare Inc. | 586.89 Million USD | 83.372% |
| NewGenIvf Group Limited | 1.63 Million USD | -5852.207% |
| Novo Integrated Sciences, Inc. | 13.5 Million USD | -622.567% |
| Option Care Health, Inc. | 666.62 Million USD | 85.361% |
| P3 Health Partners Inc. | 199.56 Million USD | 51.099% |
| P3 Health Partners Inc. | 199.56 Million USD | 51.099% |
| The Pennant Group, Inc. | 88.99 Million USD | -9.657% |
| Surgery Partners, Inc. | 319.5 Million USD | 69.456% |
| Syra Health Corp. Class A Common Stock | 4.29 Million USD | -2169.776% |
| Talkspace, Inc. | 97.58 Million USD | 0.0% |
| The Oncology Institute, Inc. | 136.59 Million USD | 28.554% |
| The Oncology Institute, Inc. | 136.59 Million USD | 28.554% |